Edition:
United States

Boston Scientific Corp (BSX)

BSX on New York Consolidated

25.28USD
21 Feb 2017
Change (% chg)

$-0.11 (-0.43%)
Prev Close
$25.39
Open
$25.51
Day's High
$25.58
Day's Low
$25.26
Volume
7,566,482
Avg. Vol
8,700,609
52-wk High
$25.65
52-wk Low
$16.82

BSX

Chart for BSX

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP),... (more)

Overall

Beta: 1.08
Market Cap(Mil.): $34,423.20
Shares Outstanding(Mil.): 1,361.68
Dividend: --
Yield (%): --

Financials

  BSX Industry Sector
P/E (TTM): 100.19 52.89 29.35
EPS (TTM): 0.25 -- --
ROI: 2.30 7.57 12.97
ROE: 5.32 11.40 14.11

U.S. top court rejects Boston Scientific's patent licensing appeal

The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

Feb 21 2017

U.S. top court rejects Boston Scientific's patent licensing appeal

The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

Feb 21 2017

UPDATE 1-U.S. top court rejects Boston Scientific's patent licensing appeal

Feb 21 The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

Feb 21 2017

U.S. Supreme Court rejects Boston Scientific's patent licensing appeal

Feb 21 The U.S. Supreme Court on Tuesday turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.

Feb 21 2017

BRIEF-Boston Scientific enters into second amended, restated credit, security agreement

* Boston Scientific Corp - Boston Scientific Corporation entered into a second amended and restated credit and security agreement - SEC filing

Feb 10 2017

BRIEF-Boston Scientific sees FY 2017 GAAP earnings per share $0.86 to $0.91

* Boston scientific announces results for fourth quarter and full year ended december 31, 2016

Feb 02 2017

Bracco, Guerbet looking for partners for Bayer radiology bids: sources

FRANKFURT Italian healthcare group Bracco is working on a potential bid for the radiology supplies unit that Germany's Bayer AG is considering selling, people close to the matter said.

Dec 07 2016

BRIEF-Nevro files lawsuit for patent infringement against Boston Scientific in the U.S.

* Nevro files lawsuit for patent infringement against Boston Scientific in the U.S.

Nov 28 2016

BRIEF-Boston Scientific acquires tissue resection device from Distal Access

* Boston Scientific Corp- specific terms of transaction were not disclosed

Nov 15 2016

BRIEF-Boston Scientific's unit Falcon Merger extends offer for all shares of EndoChoice Holdings

* Says unit, Falcon Merger Corp has extended its previously announced tender offer for all shares of EndoChoice Holdings

Nov 04 2016

More From Around the Web

Competitors

Earnings vs. Estimates